product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
beta-III Tubulin Antibody (2E9)
catalog :
NBP1-42568
quantity :
0.1 ml (also 0.025 ml)
price :
399 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
2.00E+09
reactivity :
human, rat
application :
western blot, ELISA, immunohistochemistry, immunocytochemistry, flow cytometry
more info or order :
citations: 20
Reference
Hou Y, Yang D, Wang X, Wang H, Zhang H, Wang P, et al. Pseudoginsenoside-F11 promotes functional recovery after transient cerebral ischemia by regulating the microglia/macrophage polarization in rats. Int Immunopharmacol. 2021;99:107896 pubmed publisher
Fast O, Gentry B, Strouth L, Niece M, BECKFORD F, Shell S. Polynuclear ruthenium organometallic compounds induce DNA damage in human cells identified by the nucleotide excision repair factor XPC. Biosci Rep. 2019;: pubmed publisher
Park J, Wetzel I, Marriott I, Dreau D, D Avanzo C, Kim D, et al. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer's disease. Nat Neurosci. 2018;21:941-951 pubmed publisher
Beresova L, Vesela E, Chamrad I, Voller J, Yamada M, Furst T, et al. Role of DNA Repair Factor Xeroderma Pigmentosum Protein Group C in Response to Replication Stress As Revealed by DNA Fragile Site Affinity Chromatography and Quantitative Proteomics. J Proteome Res. 2016;15:4505-4517 pubmed
Chien M, Chuang C, Chern C, Liou K, Liu D, Hou Y, et al. Salvianolic acid A alleviates ischemic brain injury through the inhibition of inflammation and apoptosis and the promotion of neurogenesis in mice. Free Radic Biol Med. 2016;99:508-519 pubmed publisher
Mohni K, Kavanaugh G, Cortez D. ATR pathway inhibition is synthetically lethal in cancer cells with ERCC1 deficiency. Cancer Res. 2014;74:2835-45 pubmed publisher
Berra C, de Oliveira C, Garcia C, Rocha C, Lerner L, Lima L, et al. Nucleotide excision repair activity on DNA damage induced by photoactivated methylene blue. Free Radic Biol Med. 2013;61:343-56 pubmed publisher
Kothandapani A, Gopalakrishnan K, Kahali B, Reisman D, Patrick S. Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity. Exp Cell Res. 2012;318:1973-86 pubmed publisher
Muenyi C, States V, Masters J, Fan T, Helm C, States J. Sodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC). J Ovarian Res. 2011;4:9 pubmed publisher
de Feraudy S, Ridd K, Richards L, Kwok P, Revet I, Oh D, et al. The DNA damage-binding protein XPC is a frequent target for inactivation in squamous cell carcinomas. Am J Pathol. 2010;177:555-62 pubmed publisher
Acu I, Liu T, Suino Powell K, Mooney S, D Assoro A, Rowland N, et al. Coordination of centrosome homeostasis and DNA repair is intact in MCF-7 and disrupted in MDA-MB 231 breast cancer cells. Cancer Res. 2010;70:3320-8 pubmed publisher
Takedachi A, Saijo M, Tanaka K. DDB2 complex-mediated ubiquitylation around DNA damage is oppositely regulated by XPC and Ku and contributes to the recruitment of XPA. Mol Cell Biol. 2010;30:2708-23 pubmed publisher
Rezvani H, Mahfouf W, Ali N, Chemin C, Ged C, Kim A, et al. Hypoxia-inducible factor-1alpha regulates the expression of nucleotide excision repair proteins in keratinocytes. Nucleic Acids Res. 2010;38:797-809 pubmed publisher
Yan T, Seo Y, Kinsella T. Differential cellular responses to prolonged LDR-IR in MLH1-proficient and MLH1-deficient colorectal cancer HCT116 cells. Clin Cancer Res. 2009;15:6912-20 pubmed publisher
Klein U, Nigg E. SUMO-dependent regulation of centrin-2. J Cell Sci. 2009;122:3312-21 pubmed publisher
Wang Y, Liu X, Matsuda A, Plunkett W. Repair of 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine-induced DNA single-strand breaks by transcription-coupled nucleotide excision repair. Cancer Res. 2008;68:3881-9 pubmed publisher
Ferguson Yates B, Li H, Dong T, Hsiao J, Oh D. Impaired repair of cyclobutane pyrimidine dimers in human keratinocytes deficient in p53 and p63. Carcinogenesis. 2008;29:70-5 pubmed
Laposa R, Huang E, Cleaver J. Increased apoptosis, p53 up-regulation, and cerebellar neuronal degeneration in repair-deficient Cockayne syndrome mice. Proc Natl Acad Sci U S A. 2007;104:1389-94 pubmed
Lovejoy C, Lock K, Yenamandra A, Cortez D. DDB1 maintains genome integrity through regulation of Cdt1. Mol Cell Biol. 2006;26:7977-90 pubmed
Ferguson B, Oh D. Proficient global nucleotide excision repair in human keratinocytes but not in fibroblasts deficient in p53. Cancer Res. 2005;65:8723-9 pubmed
product information
master code :
NBP1-42568
SKU :
NBP1-42568
product name :
beta-III Tubulin Antibody (2E9)
unit size :
0.1 ml (also 0.025 ml)
description :
The beta-III Tubulin Antibody (2E9) - BSA Free from Novus is a mouse monoclonal antibody to beta-III Tubulin. This antibody reacts with human,rat. The beta-III Tubulin Antibody (2E9) - BSA Free has been validated for the following applications: IF/IHC,Immunocytochemistry/ Immunofluorescence,Flow Cytometry,ELISA,Immunohistochemistry,Western Blot,Simple Western.
target :
beta-III Tubulin
category :
Primary Antibodies
buffer :
Ascites
clonality :
Monoclonal
clone :
2.00E+09
conjugate :
Unconjugated
host :
Mouse
immunogen :
Full length recombinant human Tubulin Beta 3 expressed in E. coli. [UniProt# Q13509].
isotype :
IgG1
purity :
Unpurified
species :
Human,Rat
theoretical molecular weight :
50 kDa
gene symbol :
TUBB3
accessionNumbers :
Q13509
applications :
IF/IHC,Immunocytochemistry/ Immunofluorescence,Flow Cytometry,ELISA,Immunohistochemistry,Western Blot,Simple Western
USD :
399 USD
alt names :
beta-4, TUBB4 CFEOM3A, tubulin beta-3 chain, Tubulin beta-4 chain, Tubulin beta-III, tubulin, beta 3, TUJ1 antigen, TUJ-1 antigen
storage :
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
more info or order :
company information
Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com
3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.